Topic: Transverse Myelitis

AstraZeneca halted its global vaccine trials after a participant in the United Kingdom developed a suspected adverse reaction. Anonymous sources reported the diagnosis as transverse myelitis, an inflammatory condition affecting the spinal cord. The pause occurred shortly after President Trump suggested a vaccine might be available before the November election, leading to political speculation regarding the timing of the announcement.